Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2019 | 1 |
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Loss of ALK hotspot mutations in relapsed neuroblastoma.
Genes Chromosomes Cancer. 2022 Dec;61(12):747-753. doi: 10.1002/gcc.23093. Epub 2022 Sep 13.
Genes Chromosomes Cancer. 2022.
PMID: 36029175
Free PMC article.
MiR-195 and Its Target SEMA6D Regulate Chemoresponse in Breast Cancer.
Baxter DE, Allinson LM, Al Amri WS, Poulter JA, Pramanik A, Thorne JL, Verghese ET, Hughes TA.
Baxter DE, et al. Among authors: allinson lm.
Cancers (Basel). 2021 Nov 28;13(23):5979. doi: 10.3390/cancers13235979.
Cancers (Basel). 2021.
PMID: 34885090
Free PMC article.
Item in Clipboard
Genomic and Expression Analyses Define MUC17 and PCNX1 as Predictors of Chemotherapy Response in Breast Cancer.
Al Amri WS, Allinson LM, Baxter DE, Bell SM, Hanby AM, Jones SJ, Shaaban AM, Stead LF, Verghese ET, Hughes TA.
Al Amri WS, et al. Among authors: allinson lm.
Mol Cancer Ther. 2020 Mar;19(3):945-955. doi: 10.1158/1535-7163.MCT-19-0940. Epub 2019 Dec 26.
Mol Cancer Ther. 2020.
PMID: 31879365
Free article.
Item in Clipboard
Use of Optical Genome Mapping to Detect Structural Variants in Neuroblastoma.
Barford RG, Whittle E, Weir L, Fong FC, Goodman A, Hartley HE, Allinson LM, Tweddle DA.
Barford RG, et al. Among authors: allinson lm.
Cancers (Basel). 2023 Oct 31;15(21):5233. doi: 10.3390/cancers15215233.
Cancers (Basel). 2023.
PMID: 37958407
Free PMC article.
Item in Clipboard
PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia.
Herriott A, Tudhope SJ, Junge G, Rodrigues N, Patterson MJ, Woodhouse L, Lunec J, Hunter JE, Mulligan EA, Cole M, Allinson LM, Wallis JP, Marshall S, Wang E, Curtin NJ, Willmore E.
Herriott A, et al. Among authors: allinson lm.
Oncotarget. 2015 Dec 22;6(41):43978-91. doi: 10.18632/oncotarget.6287.
Oncotarget. 2015.
PMID: 26539646
Free PMC article.
Item in Clipboard
Cite
Cite